Literature DB >> 11160705

Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids?

M I Barrasa1, J T Guo, J Saputelli, W S Mason, C Seeger.   

Abstract

Hepadnaviruses are enveloped viruses, each with a DNA genome packaged in an icosahedral nucleocapsid, which is the site of viral DNA synthesis. In the presence of envelope proteins, DNA-containing nucleocapsids are assembled into virions and secreted, but in the absence of these proteins, nucleocapsids deliver viral DNA into the cell nucleus. Presumably, this step is identical to the delivery of viral DNA during the initiation of an infection. Unfortunately, the mechanisms triggering the disintegration of subviral core particles and delivery of viral DNA into the nucleus are not yet understood. We now report the identification of a sequence motif resembling a serine- or threonine-proline kinase recognition site in the core protein at a location that is required for the assembly of core polypeptides into capsids. Using duck hepatitis B virus, we demonstrated that mutations at this sequence motif can have profound consequences for RNA packaging, DNA replication, and core protein stability. Furthermore, we found a mutant with a conditional phenotype that depended on the cell type used for virus replication. Our results support the hypothesis predicting that this motif plays a role in assembly and disassembly of viral capsids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160705      PMCID: PMC115152          DOI: 10.1128/JVI.75.4.2024-2028.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The crystal structure of the human hepatitis B virus capsid.

Authors:  S A Wynne; R A Crowther; A G Leslie
Journal:  Mol Cell       Date:  1999-06       Impact factor: 17.970

2.  A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L).

Authors:  T T Yuan; C Shih
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Evidence that less-than-full-length pol gene products are functional in hepadnavirus DNA synthesis.

Authors:  T T Wu; L D Condreay; L Coates; C Aldrich; W Mason
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus.

Authors:  J Summers; P M Smith; M J Huang; M S Yu
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro.

Authors:  J C Pugh; K Yaginuma; K Koike; J Summers
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.

Authors:  J S Tuttleman; J C Pugh; J W Summers
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

7.  Inhibition of Ty1 transposition by mating pheromones in Saccharomyces cerevisiae.

Authors:  H Xu; J D Boeke
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

8.  Hepatitis B virus capsid particles are assembled from core-protein dimer precursors.

Authors:  S Zhou; D N Standring
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH.

Authors:  T Kawaguchi; K Nomura; Y Hirayama; T Kitagawa
Journal:  Cancer Res       Date:  1987-08-15       Impact factor: 12.701

10.  Reassessment of the v-fms sequence: threonine phosphorylation of the COOH-terminal domain.

Authors:  U Smola; D Hennig; A Hadwiger-Fangmeier; B Schütz; E Pfaff; H Niemann; T Tamura
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more
  18 in total

1.  Nuclear import of hepatitis B virus capsids and release of the viral genome.

Authors:  Birgit Rabe; Angelika Vlachou; Nelly Panté; Ari Helenius; Michael Kann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

Review 2.  Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.

Authors:  Bidisha Mitra; Roshan J Thapa; Haitao Guo; Timothy M Block
Journal:  Antiviral Res       Date:  2018-08-24       Impact factor: 5.970

3.  Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus.

Authors:  Chunxiao Xu; Haitao Guo; Xiao-Ben Pan; Richeng Mao; Wenquan Yu; Xiaodong Xu; Lai Wei; Jinhong Chang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

4.  Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene.

Authors:  Samina Alam; Brian S Bowser; Michael J Conway; Mohd Israr; Eric J Ryndock; Long Fu Xi; Craig Meyers
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

5.  Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.

Authors:  Qiong Zhao; Zhanying Hu; Junjun Cheng; Shuo Wu; Yue Luo; Jinhong Chang; Jianming Hu; Ju-Tao Guo
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

Review 6.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

7.  Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.

Authors:  Robyn Puro; Robert J Schneider
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

Review 8.  Host factors involved in hepatitis B virus maturation, assembly, and egress.

Authors:  Reinhild Prange
Journal:  Med Microbiol Immunol       Date:  2012-09-11       Impact factor: 3.402

9.  Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.

Authors:  Haitao Guo; Dong Jiang; Tianlun Zhou; Andrea Cuconati; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

10.  Signal transduction pathways that inhibit hepatitis B virus replication.

Authors:  Michael D Robek; Bryan S Boyd; Stefan F Wieland; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.